VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $94,545,000 | -55.7% | 930,100 | -22.3% | 6.39% | -61.1% |
| Q3 2015 | $213,503,000 | -10.1% | 1,196,900 | +12.0% | 16.43% | -19.7% |
| Q2 2015 | $237,478,000 | +11.8% | 1,069,000 | 0.0% | 20.47% | +8.3% |
| Q1 2015 | $212,325,000 | +36.6% | 1,069,000 | -1.6% | 18.90% | +26.7% |
| Q4 2014 | $155,489,000 | +14.5% | 1,086,500 | +5.0% | 14.92% | +32.1% |
| Q3 2014 | $135,792,000 | -2.0% | 1,035,000 | -5.8% | 11.29% | +10.2% |
| Q2 2014 | $138,568,000 | -22.0% | 1,098,700 | -18.4% | 10.25% | -25.4% |
| Q1 2014 | $177,575,000 | +12.3% | 1,347,000 | 0.0% | 13.73% | +10.6% |
| Q4 2013 | $158,138,000 | +12.5% | 1,347,000 | 0.0% | 12.41% | +8.4% |
| Q3 2013 | $140,533,000 | +21.2% | 1,347,000 | 0.0% | 11.45% | +28.8% |
| Q2 2013 | $115,950,000 | – | 1,347,000 | – | 8.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |